Lin CHEN,Yongqing WU,Jianqin WEI,Nanette BISHOPRIC
申请号：
US15724117
公开号：
US20180028477A1
申请日:
2017.10.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides novel methods for treating cardiac remodeling and heart conditions using specific compounds, as well as compositions, and pharmaceutical formulations. In some embodiments, the compounds may inhibit acetylation of MEF2 transcription factors.
